Example of Clinical and Translational Science format
Recent searches

Example of Clinical and Translational Science format Example of Clinical and Translational Science format Example of Clinical and Translational Science format Example of Clinical and Translational Science format Example of Clinical and Translational Science format Example of Clinical and Translational Science format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Clinical and Translational Science format Example of Clinical and Translational Science format Example of Clinical and Translational Science format Example of Clinical and Translational Science format Example of Clinical and Translational Science format Example of Clinical and Translational Science format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Clinical and Translational Science — Template for authors

Publisher: Wiley
Categories Rank Trend in last 3 yrs
Pharmacology, Toxicology and Pharmaceutics (all) #9 of 67 up up by 15 ranks
Biochemistry, Genetics and Molecular Biology (all) #52 of 204 up up by 40 ranks
Neuroscience (all) #50 of 110 up up by 23 ranks
journal-quality-icon Journal quality:
High
calendar-icon Last 4 years overview: 332 Published Papers | 1677 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 27/06/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access
recommended Recommended

PLOS

Quality:  
High
CiteRatio: 11.0
SJR: 4.127
SNIP: 2.005
open access Open Access

The Royal Society

Quality:  
High
CiteRatio: 8.4
SJR: 3.078
SNIP: 1.477
open access Open Access
recommended Recommended

Elsevier

Quality:  
High
CiteRatio: 12.4
SJR: 3.822
SNIP: 2.504
open access Open Access

Elsevier

Quality:  
High
CiteRatio: 5.3
SJR: 1.131
SNIP: 1.061

Journal Performance & Insights

Impact Factor

CiteRatio

Determines the importance of a journal by taking a measure of frequency with which the average article in a journal has been cited in a particular year.

A measure of average citations received per peer-reviewed paper published in the journal.

3.373

15% from 2018

Impact factor for Clinical and Translational Science from 2016 - 2019
Year Value
2019 3.373
2018 3.989
2017 1.954
2016 0.86
graph view Graph view
table view Table view

5.1

4% from 2019

CiteRatio for Clinical and Translational Science from 2016 - 2020
Year Value
2020 5.1
2019 4.9
2018 4.2
2017 2.4
2016 1.8
graph view Graph view
table view Table view

insights Insights

  • Impact factor of this journal has decreased by 15% in last year.
  • This journal’s impact factor is in the top 10 percentile category.

insights Insights

  • CiteRatio of this journal has increased by 4% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

1.303

11% from 2019

SJR for Clinical and Translational Science from 2016 - 2020
Year Value
2020 1.303
2019 1.175
2018 0.955
2017 0.669
2016 0.36
graph view Graph view
table view Table view

1.138

11% from 2019

SNIP for Clinical and Translational Science from 2016 - 2020
Year Value
2020 1.138
2019 1.028
2018 0.893
2017 0.683
2016 0.362
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has increased by 11% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 11% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Clinical and Translational Science

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Wiley

Clinical and Translational Science

CTS: Clinical and Translational Science is your source for the most current and thought provoking original research across the broad spectrum of clinical specialties and basic science. CTS highlights investigative work bridging the gap between laboratory discovery and practice...... Read More

Pharmacology, Toxicology and Pharmaceutics

i
Last updated on
26 Jun 2020
i
ISSN
1752-8054
i
Impact Factor
High - 1.013
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
Blue faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
apa
i
Citation Type
Numbered
[25]
i
Bibliography Example
Beenakker, C.W.J. (2006) Specular andreev reflection in graphene.Phys. Rev. Lett., 97 (6), 067 007. URL 10.1103/PhysRevLett.97.067007.

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.1111/J.1752-8062.2011.00347.X
Recommendations for Planning Pilot Studies in Clinical and Translational Research
Charity G. Moore1, Rickey E. Carter2, Paul J. Nietert3, Paul W. Stewart4

Abstract:

Advances in clinical and translation science are facilitated by building on prior knowledge gained through experimentation and observation. In the context of drug development, preclinical studies are followed by a progression of phase I through phase IV clinical trials. At each step, the study design and statistical strategie... Advances in clinical and translation science are facilitated by building on prior knowledge gained through experimentation and observation. In the context of drug development, preclinical studies are followed by a progression of phase I through phase IV clinical trials. At each step, the study design and statistical strategies are framed around research questions that are prerequisites for the next phase. In other types of biomedical research, pilot studies are used for gathering preliminary support for the next research step. However, the phrase "pilot study" is liberally applied to projects with little or no funding, characteristic of studies with poorly developed research proposals, and usually conducted with no detailed thought of the subsequent study. In this article, we present a rigorous definition of a pilot study, offer recommendations for the design, analysis and sample size justification of pilot studies in clinical and translational research, and emphasize the important role that well-designed pilot studies play in the advancement of science and scientific careers. read more read less

Topics:

Translational research (51%)51% related to the paper
View PDF
412 Citations
Patent DOI: 10.1111/J.1752-8062.2008.00053.X
Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans
Joseph V. Bonventre1, Vishal S. Vaidya1

Abstract:

The present invention is directed to acute kidney injury biomarkers, and methods and kits comprising the use of agents directed against acute kidney injury biomarkers for facilitating and enhancing the diagnosis of AKI. The present invention is based on the discovery that specific biomarkers are present in urine at higher con... The present invention is directed to acute kidney injury biomarkers, and methods and kits comprising the use of agents directed against acute kidney injury biomarkers for facilitating and enhancing the diagnosis of AKI. The present invention is based on the discovery that specific biomarkers are present in urine at higher concentrations in subjects with acute kidney injury (AKI) as compared with subjects that have no symptoms of AKI. The invention is directed to methods for diagnosis of AKI by determining and monitoring the levels of at least one biomarker protein in a biological sample, such as urine. Further, the invention is directed to methods for facilitating the distinction of kidney infection from bladder infection in a subject. read more read less

Topics:

Acute kidney injury (59%)59% related to the paper, Renal replacement therapy (55%)55% related to the paper, Kidney infection (53%)53% related to the paper
View PDF
345 Citations
open accessOpen access Journal Article DOI: 10.1111/CTS.12692
Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group.

Abstract:

Translating CYP2D6 genotype to metabolizer phenotype is not standardized across clinical laboratories offering pharmacogenetic (PGx) testing and PGx clinical practice guidelines, such as the Clinical Pharmacogenetics Implementation Consortium (CPIC) and the Dutch Pharmacogenetics Working Group (DPWG). The genotype to phenotyp... Translating CYP2D6 genotype to metabolizer phenotype is not standardized across clinical laboratories offering pharmacogenetic (PGx) testing and PGx clinical practice guidelines, such as the Clinical Pharmacogenetics Implementation Consortium (CPIC) and the Dutch Pharmacogenetics Working Group (DPWG). The genotype to phenotype translation discordance between laboratories and guidelines can cause discordant cytochrome P450 2D6 (CYP2D6) phenotype assignments and, thus lead to inconsistent therapeutic recommendations and confusion among patients and clinicians. A modified-Delphi method was used to obtain consensus for a uniform system for translating CYP2D6 genotype to phenotype among a panel of international CYP2D6 experts. Experts with diverse involvement in CYP2D6 interpretation (clinicians, researchers, genetic testing laboratorians, and PGx implementers; n = 37) participated in conference calls and surveys. After completion of 7 surveys, a consensus (> 70%) was reached with 82% of the CYP2D6 experts agreeing to the final CYP2D6 genotype to phenotype translation method. Broad adoption of the proposed CYP2D6 genotype to phenotype translation method by guideline developers, such as CPIC and DPWG, and clinical laboratories as well as researchers will result in more consistent interpretation of CYP2D6 genotype. read more read less

Topics:

Pharmacogenetics (50%)50% related to the paper
View PDF
300 Citations
open accessOpen access Journal Article DOI: 10.1111/J.1752-8062.2008.00026.X
Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 Diabetes

Abstract:

Objectives: Chronic subacute inflammation is implicated in the pathogenesis of insulin resistance and type 2 diabetes. Salicylates were shown years ago to lower glucose and more recently to inhibit NF-κB activity. Salsalate, a prodrug form of salicylate, has seen extensive clinical use and has a favorable safety profile. We s... Objectives: Chronic subacute inflammation is implicated in the pathogenesis of insulin resistance and type 2 diabetes. Salicylates were shown years ago to lower glucose and more recently to inhibit NF-κB activity. Salsalate, a prodrug form of salicylate, has seen extensive clinical use and has a favorable safety profile. We studied the efficacy of salsalate in reducing glycemia and insulin resistance and potential mechanisms of action to validate NF-κB as a potential pharmacologic target in diabetes. Methods and Results: In open label studies, both high (4.5 g/d) and standard (3.0 g/d) doses of salsalate reduced fasting and postchallenge glucose levels after 2 weeks of treatment. Salsalate increased glucose utilization during euglycemic hyperinsulinemic clamps, by approximately 50% and 15% at the high and standard doses, respectively, and insulin clearance was decreased. Dose-limiting tinnitus occurred only at the higher dose. In a third, double-masked, placebo-controlled trial, 1 month of salsalate at maximum tolerable dose (no tinnitus) improved fasting and postchallenge glucose levels. Circulating free fatty acids were reduced and adiponectin increased in all treated subjects. Conclusions: These data demonstrate that salsalate improves in vivo glucose and lipid homeostasis, and support targeting of inflammation and NF-κB as a therapeutic approach in type 2 diabetes. read more read less

Topics:

Salsalate (81%)81% related to the paper, Insulin resistance (62%)62% related to the paper, Glucose tolerance test (58%)58% related to the paper, Insulin (56%)56% related to the paper, Hyperinsulinism (56%)56% related to the paper
View PDF
281 Citations
open accessOpen access Journal Article DOI: 10.1111/CTS.12178
Big Data and Large Sample Size: A Cautionary Note on the Potential for Bias
Robert M. Kaplan1, David A. Chambers1, Russell E. Glasgow2

Abstract:

A number of commentaries have suggested that large studies are more reliable than smaller studies and there is a growing interest in the analysis of “big data” that integrates information from many thousands of persons and/or different data sources. We consider a variety of biases that are likely in the era of big data, inclu... A number of commentaries have suggested that large studies are more reliable than smaller studies and there is a growing interest in the analysis of “big data” that integrates information from many thousands of persons and/or different data sources. We consider a variety of biases that are likely in the era of big data, including sampling error, measurement error, multiple comparisons errors, aggregation error, and errors associated with the systematic exclusion of information. Using examples from epidemiology, health services research, studies on determinants of health, and clinical trials, we conclude that it is necessary to exercise greater caution to be sure that big sample size does not lead to big inferential errors. Despite the advantages of big studies, large sample size can magnify the bias associated with error resulting from sampling or study design. Clin Trans Sci 2014; Volume #: 1–5 read more read less

Topics:

Sample size determination (54%)54% related to the paper, Big data (50%)50% related to the paper
View PDF
279 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Clinical and Translational Science.

It automatically formats your research paper to Wiley formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Clinical and Translational Science format uses apa citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Clinical and Translational Science in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Clinical and Translational Science guidelines and auto format it.

2. Do you follow the Clinical and Translational Science guidelines?

Yes, the template is compliant with the Clinical and Translational Science guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Clinical and Translational Science?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Clinical and Translational Science citation style.

4. Can I use the Clinical and Translational Science templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Clinical and Translational Science.

5. Can I use a manuscript in Clinical and Translational Science that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Clinical and Translational Science that you can download at the end.

6. How long does it usually take you to format my papers in Clinical and Translational Science?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Clinical and Translational Science.

7. Where can I find the template for the Clinical and Translational Science?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Clinical and Translational Science's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Clinical and Translational Science's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Clinical and Translational Science an online tool or is there a desktop version?

SciSpace's Clinical and Translational Science is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Clinical and Translational Science?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Clinical and Translational Science?”

11. What is the output that I would get after using Clinical and Translational Science?

After writing your paper autoformatting in Clinical and Translational Science, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Clinical and Translational Science's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Clinical and Translational Science?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Clinical and Translational Science. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Clinical and Translational Science?

The 5 most common citation types in order of usage for Clinical and Translational Science are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Clinical and Translational Science?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Clinical and Translational Science's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Clinical and Translational Science in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Clinical and Translational Science Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Clinical and Translational Science formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template